We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.91%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$619M
AUM Growth
+$153M
Cap. Flow
+$108M
Cap. Flow %
17.48%
Top 10 Hldgs %
23.79%
Holding
1,975
New
1,076
Increased
246
Reduced
281
Closed
278

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.9M
2
NUE icon
Nucor
NUE
+$2.82M
3
LKM
Link Motion Inc.
LKM
+$2.62M
4
GLD icon
SPDR Gold Trust
GLD
+$2.26M
5
GDI
GARDNER DENVER,INC
GDI
+$2.25M

Sector Composition

Rank Sector Weight
1 Energy 11.58%
2 Consumer Discretionary 7.63%
3 Industrials 6.66%
4 Technology 6.27%
5 Real Estate 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRE
301
DELISTED
Veris Residential
VRE
$472K 0.08%
+21,500
New +$490K
MAKO
302
PUT
DELISTED
MAKO SURGICAL CORP COM
MAKO
$472K 0.08%
16,000
RUE
303
DELISTED
RUE21 INC COM STK (DE)
RUE
$472K 0.08%
+11,700
New +$484K
VXX
304
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$472K 0.08%
502
+279
+125% +$280K
TBT icon
305
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$314M
$470K 0.08%
6,250
+4,250
+213% +$328K
HST icon
306
Host Hotels & Resorts
HST
$16B
$468K 0.08%
26,495
-13,950
-34% -$247K
APO icon
307
Apollo Global Management
APO
$73.7B
$464K 0.07%
16,432
-31,354
-66% -$841K
BIB icon
308
ProShares Ultra NASDAQ Biotechnology
BIB
$83.2M
$464K 0.07%
+14,248
New +$413K
RSO
309
DELISTED
Resource Capital Corp.
RSO
$463K 0.07%
+19,500
New +$479K
ALXN
310
DELISTED
Alexion Pharmaceuticals
ALXN
$461K 0.07%
3,972
-6,000
-60% -$658K
RHT
311
PUT
DELISTED
Red Hat Inc
RHT
$461K 0.07%
+10,000
New +$507K
PEB icon
312
Pebblebrook Hotel Trust
PEB
$2.08B
$459K 0.07%
+16,002
New +$437K
MHK icon
313
Mohawk Industries
MHK
$8.97B
$456K 0.07%
+3,500
New +$427K
EIX icon
314
Edison International
EIX
$25.9B
$452K 0.07%
+9,822
New +$464K
CMCSA icon
315
Comcast
CMCSA
$89.3B
$451K 0.07%
20,000
+15,200
+317% +$331K
LRN icon
316
Stride
LRN
$3.4B
$451K 0.07%
14,613
+3,700
+34% +$118K
META icon
317
Meta Platforms (Facebook)
META
$1.5T
$447K 0.07%
8,900
-5,538
-38% -$206K
HRG
318
DELISTED
HRG Group, Inc.
HRG
$445K 0.07%
42,909
-22,400
-34% -$198K
EOPN
319
DELISTED
E2OPEN INC COM STK (DE)
EOPN
$442K 0.07%
19,722
+5,000
+34% +$103K
AEP icon
320
American Electric Power
AEP
$68.2B
$440K 0.07%
+10,154
New +$452K
TSRO
321
CALL
DELISTED
TESARO, Inc.
TSRO
$438K 0.07%
+11,300
New +$414K
ELX
322
DELISTED
EMULEX CORP
ELX
$438K 0.07%
+56,500
New +$439K
ATHN
323
DELISTED
Athenahealth, Inc.
ATHN
$434K 0.07%
4,000
ATHN
324
PUT
DELISTED
Athenahealth, Inc.
ATHN
$434K 0.07%
+4,000
New +$432K
SYK icon
325
Stryker
SYK
$129B
$433K 0.07%
6,400

Similar funds

Prelude Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Prelude Capital Management held 1,975 positions worth $619M, up 33% from $466M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Prelude Capital Management deployed $108M of net new capital in Q3 2013, opening 1,076 new positions and adding to 246 existing holdings. Its largest new stake was NetApp: 82,300 shares worth $3.51M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Apple, an estimated $2.9M trimmed.

  • Prelude Capital Management's largest Q3 2013 buy was NetApp: 82,300 shares worth $3.51M.
  • Prelude Capital Management added most to Herc Holdings in Q3 2013, an estimated $2.74M increase.
  • Prelude Capital Management's biggest Q3 2013 reduction was Apple, cutting an estimated $2.9M.
  • Prelude Capital Management fully exited Nucor in Q3 2013, selling an estimated $2.82M.
  • Prelude Capital Management's ten largest holdings make up 24% of its $619M portfolio in Q3 2013.
  • Prelude Capital Management opened 1,076 new positions and closed 278 in Q3 2013.
  • Prelude Capital Management's portfolio value rose 33% quarter-over-quarter to $619M.

Based on Prelude Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.